← Eichor
Condition: Ependymoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ependymoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
NA · 1 location(s) · Shengjing Hospital · NCT05957679A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refra
EARLY_Phase 1 · 1 location(s) · Children's National Research Institute · NCT07017816Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT06779487An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
Phase 2/Phase 3 · 40 location(s) · Centre Leon Berard · NCT02265770International HIT-MED Registry (I-HIT-MED)
Phase N/A · 57 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT02417324Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Phase 1 · 1 location(s) · Children's National Research Institute · NCT06193759ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Phase 1 · 7 location(s) · Sabine Mueller, MD, PhD · NCT04732065PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161519Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Natural History Study of Patients With Neurofibromatosis Type 2
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT00598351Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
Phase 2 · 5 location(s) · University of California, San Francisco · NCT07226453Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
Phase 2 · 2 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT07424092Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Phase 2 · 6 location(s) · Scott R. Plotkin, MD, PhD · NCT04374305LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
Phase 1 · 2 location(s) · M.D. Anderson Cancer Center · NCT03750513Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors
Phase N/A · 1 location(s) · University Hospital Muenster · NCT07056023Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Gliom
Phase 1 · 1 location(s) · Seattle Children's Hospital · NCT04185038Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05672043Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Phase 1 · 1 location(s) · Jazz Pharmaceuticals · NCT04541082Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
NA · 8 location(s) · University of California, San Francisco · NCT05057702Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Phase 1/Phase 2 · 4 location(s) · Nationwide Children's Hospital · NCT05278208Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents
Phase N/A · 1 location(s) · Institut Claudius Regaud · NCT05151718HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 · 3 location(s) · M.D. Anderson Cancer Center · NCT03911388Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 202
Phase N/A · 42 location(s) · European Organisation for Research and Treatment of Cancer - · NCT05259605Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Phase N/A · 3 location(s) · Maastricht Radiation Oncology · NCT04648462Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Phase 1 · 1 location(s) · Theodore S. Johnson · NCT05106296Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Phase 2 · 22 location(s) · Medical University of Vienna · NCT01356290
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.